4th Quarter - Report — SAM ACTION, INC. for SAM ACTION, INC. (2022)

Firm

SAM ACTION, INC.

Client

SAM ACTION, INC.

Income

—

Expenses

$30,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

MORE Act (H.R. 3617), Cannabis Administration and Opportunity Act (S. 4591), Protecting Kids from Candy-Flavored Drugs Act (H.R. 8839), Combating Violent and Dangerous Crime Act (S. 4628), States Reform Act (H.R. 5977).

Lobbyist	Covered position, as disclosed
JORDAN DAVIDSON New	—

Contacted: HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 8839 (117th), H.R. 5977 (117th), H.R. 3617 (117th), S. 4628 (117th), S. 4591 (117th)

Medical/Disease Research/Clinical Labs MED

Medical Marijuana and Cannabidiol Research Expansion Act (S. 253, H.R. 8454).

Lobbyist	Covered position, as disclosed
JORDAN DAVIDSON New	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 8454 (117th), S. 253 (117th)

Banking BAN

SAFE Banking Act (H.R. 1996, S. 910).

Lobbyist	Covered position, as disclosed
JORDAN DAVIDSON New	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1996 (117th), S. 910 (117th)

Alcohol and Drug Abuse ALC

Appropriations amendment related to federal funding for studying marijuanas impact on mental health.

Lobbyist	Covered position, as disclosed
JORDAN DAVIDSON New	—

Contacted: SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.